Atul Ltd
Atul Ltd
CommoditiesAtul Ltd. is a diversified and integrated Indian chemical company (a part of Lalbhai Group, Gujarat). The products of the company are used in various Industries and come mainly under two segments, Life Science Chemicals and Performance and Other Chemicals under 9 Businesses. [1] Since its incorporation, the company has manufactured many products for the first time in India Dyes including Vat Dyes, crop care chemicals, Phosgene, Carbamite, 2,4-D Acid, para Cresol, tissue culture raised date palms. [2]
Atul Ltd is nearly debt-free with a TTM profit growth of 39%, but a 3-year ROE of just 9% and negative stock CAGR over 5 years (-6%) suggest the market is not rewarding its capital allocation. At a PE of 27.8x for a specialty chemicals company delivering only 5% sales CAGR over 3 years, the valuation appears stretched relative to growth.
Key Fundamentals
SmallcapSpecialty ChemicalsChemicalsTechnical Indicators
Key Insights
Strengths
1- Company is almost debt free.
Weaknesses
4- Stock is trading at 3.13 times its book value
- The company has delivered a poor sales growth of 11.0% over past five years.
- Company has a low return on equity of 9.13% over last 3 years.
- Working capital days have increased from 104 days to 165 days
Growth Rate
AI Analysis — Bull vs Bear
Atul Ltd is nearly debt-free with a TTM profit growth of 39%, but a 3-year ROE of just 9% and negative stock CAGR over 5 years (-6%) suggest the market is not rewarding its capital allocation. At a PE of 27.8x for a specialty chemicals company delivering only 5% sales CAGR over 3 years, the valuation appears stretched relative to growth.
- Company is almost debt-free, providing strong balance sheet resilience and financial flexibility in a capital-intensive chemicals sector
- TTM compounded profit growth of 39% signals a sharp earnings recovery and potential margin expansion
- 70% of analysts (7 out of 10) rate the stock a Buy, indicating broad Street confidence in medium-term prospects
- 10-year stock CAGR of 13% demonstrates long-term wealth creation track record for patient investors
- 10-year compounded sales growth of 9% reflects a steady demand base and diversified product portfolio across life sciences and performance chemicals
- 10-year ROE of 13% shows the company has historically generated reasonable returns on shareholder equity
- TTM sales growth of 12% indicates an acceleration from the 3-year CAGR of 5%, suggesting a demand recovery is underway
- 3-year ROE of only 9% is well below cost of equity for a specialty chemicals company, indicating poor capital efficiency
- Working capital days have deteriorated sharply from 104 days to 165 days, locking up cash and signalling potential collection or inventory issues
- 5-year stock CAGR of -6% means the stock has destroyed value for medium-term investors despite underlying business growth
- PE of 27.8x is expensive given only 5% compounded sales growth over 3 years and 1% profit CAGR over 5 years
- Price-to-book of 3.07x is elevated for a business delivering sub-10% ROE, implying the market is pricing in a turnaround not yet visible in fundamentals
- Dividend yield of just 0.46% offers minimal income support while investors wait for capital appreciation
- 5-year compounded profit growth of only 1% indicates the recent 39% TTM spike may be a one-off recovery rather than a sustainable trend
- 1-year stock return of -6% shows continued negative momentum and lack of near-term catalysts
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Promoter share encumbrance disclosure Jun 4
Atul Limited disclosed FY26 share encumbrance status. Promoters have pledged 1.30 lakh shares, representing 0.44% of total paid-up capital.
TL;DR: Limited news flow for Atul Ltd in this period. The only disclosure is a routine share encumbrance filing showing a minimal 0.44% promoter pledge, which poses no material concern. No operational or financial updates to signal a change in trend.
Quarterly Results
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,195 | 1,182 | 1,194 | 1,138 | 1,212 | 1,322 | 1,393 | 1,417 | 1,452 | 1,478 | 1,552 | 1,574 | 1,670 |
| Expenses | 1,046 | 1,000 | 1,039 | 986 | 1,065 | 1,099 | 1,150 | 1,193 | 1,229 | 1,242 | 1,284 | 1,327 | 1,389 |
| Operating Profit | 149 | 182 | 155 | 152 | 148 | 223 | 243 | 224 | 223 | 236 | 267 | 247 | 281 |
| OPM % | 12% | 15% | 13% | 13% | 12% | 17% | 17% | 16% | 15% | 16% | 17% | 16% | 17% |
| Other Income | 26 | 10 | 24 | 17 | 16 | 16 | 35 | 19 | 50 | 28 | 50 | 40 | 92 |
| Interest | 2 | 2 | 2 | 2 | 5 | 5 | 9 | 4 | 5 | 5 | 5 | 4 | 4 |
| Depreciation | 51 | 52 | 54 | 61 | 76 | 77 | 78 | 81 | 82 | 82 | 81 | 80 | 79 |
| PBT | 122 | 138 | 124 | 105 | 83 | 158 | 191 | 158 | 186 | 177 | 231 | 203 | 289 |
| Tax % | 24% | 26% | 26% | 32% | 29% | 29% | 27% | 26% | 30% | 25% | 21% | 20% | 27% |
| Net Profit | 92 | 102 | 91 | 72 | 59 | 112 | 140 | 117 | 130 | 132 | 182 | 164 | 211 |
| EPS in Rs | 31.7 | 35.02 | 30.6 | 24.04 | 19.84 | 38 | 46.47 | 36.93 | 42.97 | 43.4 | 60.88 | 54.6 | 71.38 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,637 | 2,595 | 2,834 | 3,514 | 4,038 | 4,093 | 3,731 | 5,081 | 5,428 | 4,726 | 5,583 | 6,274 |
| Expenses | 2,235 | 2,134 | 2,324 | 3,008 | 3,270 | 3,191 | 2,813 | 4,168 | 4,620 | 4,086 | 4,665 | 5,243 |
| Operating Profit | 402 | 461 | 510 | 505 | 768 | 902 | 918 | 913 | 807 | 639 | 918 | 1,031 |
| OPM % | 15% | 18% | 18% | 14% | 19% | 22% | 25% | 18% | 15% | 14% | 16% | 16% |
| Other Income | 9 | 37 | 57 | 30 | 38 | 83 | 109 | 82 | 86 | 65 | 115 | 209 |
| Interest | 26 | 28 | 25 | 13 | 7 | 9 | 9 | 9 | 8 | 11 | 24 | 17 |
| Depreciation | 60 | 66 | 95 | 110 | 119 | 130 | 136 | 177 | 198 | 243 | 317 | 322 |
| PBT | 326 | 404 | 446 | 412 | 680 | 845 | 882 | 810 | 688 | 451 | 692 | 900 |
| Tax % | 31% | 32% | 28% | 32% | 36% | 21% | 25% | 25% | 26% | 28% | 28% | 23% |
| Net Profit | 240 | 274 | 323 | 281 | 436 | 671 | 660 | 605 | 507 | 324 | 499 | 689 |
| EPS in Rs | 81.13 | 92.44 | 109 | 93.21 | 146 | 225 | 222 | 204 | 174 | 110 | 164 | 230 |
| Div. Payout % | 10% | 9% | 9% | 13% | 10% | 12% | 9% | 12% | 19% | 18% | 15% | 13% |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 29 | 29 | 29 |
| Reserves | 1,009 | 1,585 | 1,936 | 2,214 | 2,676 | 3,125 | 3,797 | 4,399 | 4,642 | 5,085 | 5,569 | 6,192 |
| Borrowings | 299 | 316 | 168 | 16 | 55 | 108 | 133 | 144 | 52 | 237 | 202 | 183 |
| Other Liabilities | 485 | 535 | 591 | 749 | 783 | 880 | 976 | 1,117 | 1,028 | 1,104 | 1,179 | 1,496 |
| Total Liabilities | 1,823 | 2,465 | 2,724 | 3,009 | 3,543 | 4,144 | 4,935 | 5,690 | 5,752 | 6,455 | 6,980 | 7,900 |
| Fixed Assets | 514 | 750 | 1,026 | 1,027 | 1,104 | 1,125 | 1,418 | 1,634 | 1,770 | 2,792 | 2,847 | 2,676 |
| CWIP | 112 | 180 | 59 | 96 | 172 | 368 | 250 | 420 | 1,033 | 281 | 124 | 110 |
| Investments | 66 | 382 | 429 | 470 | 752 | 1,137 | 1,361 | 1,339 | 881 | 1,392 | 1,766 | 2,592 |
| Other Assets | 1,131 | 1,154 | 1,210 | 1,415 | 1,515 | 1,513 | 1,906 | 2,297 | 2,068 | 1,990 | 2,242 | 2,523 |
| Total Assets | 1,823 | 2,465 | 2,724 | 3,009 | 3,543 | 4,144 | 4,935 | 5,690 | 5,752 | 6,455 | 6,980 | 7,900 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 306 | 401 | 392 | 356 | 404 | 881 | 718 | 231 | 707 | 667 | 603 | 1,023 |
| Investing | -167 | -375 | -175 | -129 | -408 | -782 | -645 | -163 | -469 | -683 | -494 | -895 |
| Financing | -124 | -39 | -212 | -207 | -1 | -111 | -52 | -57 | -257 | 38 | -118 | -98 |
| Net Cash Flow | 16 | -13 | 5 | 19 | -5 | -11 | 21 | 11 | -20 | 22 | -9 | 30 |
| Free Cash Flow | 111 | 31 | 180 | 213 | 195 | 508 | 396 | -359 | -167 | 164 | 334 | 851 |
| CFO/OP | 95 | 111 | 93 | 91 | 86 | 122 | 100 | 47 | 112 | 121 | 82 | 114 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61 | 62 | 67 | 75 | 63 | 64 | 72 | 71 | 57 | 72 | 74 | 74 |
| Inventory Days | 105 | 118 | 107 | 83 | 89 | 93 | 128 | 122 | 101 | 90 | 97 | 90 |
| Days Payable | 69 | 87 | 86 | 93 | 66 | 88 | 121 | 90 | 69 | 84 | 82 | 94 |
| Cash Conversion Cycle | 97 | 93 | 88 | 66 | 86 | 69 | 78 | 103 | 89 | 77 | 89 | 70 |
| Working Capital Days | 50 | 46 | 65 | 76 | 74 | 59 | 65 | 77 | 68 | 69 | 77 | 165 |
| ROCE % | 26% | 26% | 23% | 19% | 27% | 28% | 24% | 19% | 15% | 9% | 13% | 15% |
Documents
Frequently Asked Questions about Atul Ltd
What does Atul Ltd do?
Where is Atul Ltd (ATUL) listed?
Which sector does Atul Ltd belong to?
What is the market capitalisation of Atul Ltd?
What is the PE ratio of Atul Ltd?
What is the 52-week high and low of Atul Ltd?
Does Atul Ltd pay dividends?
What is the Return on Equity (ROE) of Atul Ltd?
How can I research Atul Ltd on Tapetide?
Company Information
Atul Ltd. is a diversified and integrated Indian chemical company (a part of Lalbhai Group, Gujarat). The products of the company are used in various Industries and come mainly under two segments, Life Science Chemicals and Performance and Other Chemicals under 9 Businesses. [1] Since its incorporation, the company has manufactured many products for the first time in India Dyes including Vat Dyes, crop care chemicals, Phosgene, Carbamite, 2,4-D Acid, para Cresol, tissue culture raised date palms. [2]